Blood test may cut hospital stays for preeclampsia
NCT ID NCT03289611
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a blood test measuring the sFlt-1/PlGF ratio can help doctors decide the best care for pregnant people with suspected preeclampsia before 35 weeks. 84 participants were randomly assigned to have their care guided by the test or usual care. The goal was to see if the test could reduce hospital stays and costs while keeping mothers and babies safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sFlt-1/PlGF ratio blood test
What this could lead to
If successful, this test could help doctors decide who needs hospital care for preeclampsia, reducing unnecessary stays and costs.
What could go wrong
This is a small, completed study with 84 participants. The test may not be accurate enough for all patients, and results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Cochin, Maternité Port Royal
Paris, 75014, France